Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, April 27, 2026 (GLOBE NEWSWIRE) -- The "Women's Digital Health Market Report 2026" has been added to ResearchAndMarkets.com's offering. The women's digital health market is experiencing...
-
RNK Health outlines its clinician-guided NAD+ therapy model, including telehealth structure, prescribing process, and program details
-
IVY Rx releases 2026 compounded GLP-1 telehealth program information covering pricing tiers, clinician access, and pharmacy fulfillment details.
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Internet of Medical Things (IoMT) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Internet of Medical Things (IoMT)...
-
TrimRx GLP-1 telehealth platform evaluated: compounded semaglutide, tirzepatide options, pricing, refund terms, and FDA-approved alternatives.
-
MEDVI Quad prescription information updated as consumer interest in prescription erectile dysfunction treatment access through telehealth grows
-
Oral Wegovy launch expands GLP-1 format options as Direct Meds telehealth platform compares FDA-approved vs compounded semaglutide pricing structures.
-
SynergyRx outlines how its telehealth platform connects patients with licensed providers for GLP-1 evaluation, pricing context, and pathways.
-
Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Women's Digital Health Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. Senior leaders in healthcare are...
-
Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America Digital Health Market Report by Technology, Component, Application, End Use, Countries and Company Analysis, 2025-2033" report has been...